NIH-funded research R15 grant

How cells manage stress from misfolded proteins

Official title: Genetic Regulation of Stress Responses at the Endoplasmic Reticulum

Funded at Western Washington University · NIH-11043203 · Data updated 2026-11-12

This study is looking at how cells handle stress from misfolded proteins, focusing on a protein called VIMP, and it's for anyone interested in understanding how our cells keep themselves healthy when faced with challenges.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWestern Washington University
NIH-funded
Lab location1 site (Bellingham, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2027
Funding year2025
Award (this year)$401,429
NIH project number1R15GM157704-01
Project IDNIH-11043203 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to protein misfolding, such as neurodegenerative diseases or certain metabolic disorders.

Less likely to help

Patients with conditions unrelated to protein misfolding or those who do not exhibit cellular stress responses may not benefit from this research.

What this research studies

This research investigates how cells respond to stress caused by misfolded proteins, focusing on a specific protein called VIMP that plays a role in the Endoplasmic Reticulum's (ER) ability to manage protein quality. Using the model organism C. elegans, the study will explore the mechanisms of ER-associated degradation (ERAD) to understand how cells balance the removal of harmful proteins while preserving functional ones. The research employs advanced techniques such as CRISPR-Cas modification and fluorescence microscopy to uncover the biochemical roles of VIMP in regulating stress responses. By understanding these processes, the research aims to shed light on how cellular stress impacts overall health.

Why it matters

Potential benefit: If successful, this research could lead to new insights into treating diseases related to protein misfolding, potentially improving patient outcomes.

How similar studies have gone: Previous research has shown success in understanding protein quality control mechanisms, making this approach promising but still exploring specific roles of VIMP in stress responses.

Where this research is happening

  • Western Washington University
    Bellingham, United States
    Active

Researchers

  • Principal investigator: Dahlberg, Caroline Lund — Western Washington University
  • Study coordinator: Dahlberg, Caroline Lund

Related research

Other NIH-funded projects on the same topics.

  • Understanding how CK1 enzymes choose their targets in DNA repair

    Scientists are studying a human-related cancer pathway to learn how a family of enzymes (CK1) decides which proteins to modify during DNA repair, with the goal of guiding new cancer therapies.

    NIH research Western Washington University · Bellingham, United States · NIH-11360619

  • RHOA signaling and brain vessel health in dementia

    A study testing how a protein called RHOA affects brain blood vessels to understand its connection to Alzheimer’s-related dementia.

    NIH research Western Washington University · Bellingham, United States · NIH-11291030

  • Improving cannabidiol treatments for autism spectrum disorder

    This study is looking at how different mixes of CBD and natural compounds from cannabis can help improve brain function in kids and teens with autism, aiming to find safer and more effective treatments without the high from THC.

    NIH research Western Washington University · Bellingham, United States · NIH-11043199

  • Understanding how bacteria attach proteins to their cell walls

    This study is looking at special enzymes that help bacteria stick proteins to their surfaces, with the goal of improving how we create new treatments for infections, which could help patients dealing with antibiotic-resistant bacteria.

    NIH research Western Washington University · Bellingham, United States · NIH-10874337

  • Improving drug synthesis using safer chemical reactions

    This study is looking for better and safer ways to make medicines that can help treat different diseases, using a new method that could make the process easier and more effective for everyone.

    NIH research Western Washington University · Bellingham, United States · NIH-10436072

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.